Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81

Huang, Chung-FengHuang, Ching-IYeh, Ming-LunWang, Shu-ChiChen, Kuan-YuKo, Yu-MinLin, Ching-ChihTsai, Yi-ShanTsai, Pei-ChienLin, Zu-YauChen, Shinn-CherngDai, Chia-YenHuang, Jee-FuChuang, Wan-LongYu, Ming-Lung2017-12-062017Huang, C., C. Huang, M. Yeh, S. Wang, K. Chen, Y. Ko, C. Lin, et al. 2017. “Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89].” EBioMedicine 17 (1): 237. doi:10.1016/j.ebiom.2017.02.027. http://dx.doi.org/10.1016/j.ebiom.2017.02.027.http://nrs.harvard.edu/urn-3:HUL.InstRepos:34493131en-USCorrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]Journal Article2017-12-0610.1016/j.ebiom.2017.02.027